Repositive initiates partnership with Xpressomics
10 February 2016
Repositive, a software company developing novel tools to improve access to human genomic research data, has announced a deal with Xpressomics, a genes expression search engine
In January 2020 the American Diabetes Association released a new set of clinical standards that, for the first time, included the use of an FDA-approved autonomous artificial intelligence (AI) platform for detecting diabetic retinopathy in people with diabetes.
